Keiko Kagami

677 total citations
37 papers, 379 citations indexed

About

Keiko Kagami is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Keiko Kagami has authored 37 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 11 papers in Molecular Biology. Recurrent topics in Keiko Kagami's work include Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Keiko Kagami is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Keiko Kagami collaborates with scholars based in Japan, United States and Norway. Keiko Kagami's co-authors include Kanji Sugita, Kumiko Goi, Takeshi Inukai, Shinpei Nakazawa, Koshi Akahane, Atsushi Nemoto, Atsushi Watanabe, Michiyo Okada, Masako Abe and Kazuya Takahashi and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Keiko Kagami

35 papers receiving 373 citations

Peers

Countries citing papers authored by Keiko Kagami

Since Specialization

Citations

This map shows the geographic impact of Keiko Kagami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Kagami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Kagami more than expected).

Fields of papers citing papers by Keiko Kagami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Kagami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Kagami. The network helps show where Keiko Kagami may publish in the future.

Co-authorship network of co-authors of Keiko Kagami

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Kagami. A scholar is included among the top collaborators of Keiko Kagami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Kagami. Keiko Kagami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System 2025 ·Cancer Medicine ·Minori Tamai, (unknown), Keiko Kagami, (unknown), Koshi Akahane, Kumiko Goi, Kanji Sugita, (unknown), Toshihiko Imamura, Hiroaki Goto, Takeshi Inukai	1
2	CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model 2023 ·Molecular Pharmacology ·Thao Nguyen, Yoïchi Tanaka, Masashi Sanada, (unknown), Minori Tamai, Keiko Kagami, (unknown), (unknown), Daisuke Harama, (unknown), Atsushi Watanabe, (unknown), Kumiko Goi, Takeshi Inukai	1
3	Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia 2022 ·The Journal of Steroid Biochemistry and Molecular Biology ·Minori Tamai, (unknown), Koshi Akahane, Thao Nguyen, Keiko Kagami, (unknown), Masako Abe, Atsushi Watanabe, Kumiko Goi, Kunio Miyake, Toshiya Inaba, Junko Takita, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Kanji Sugita, Takeshi Inukai	7
4	Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis 2022 ·Cancer Gene Therapy ·Minori Tamai, Shinichi Fujisawa, Thao Nguyen, (unknown), Keiko Kagami, Kenji Kamimoto, Kohei Omachi, (unknown), Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kazuhito Naka, Tadashi Kaname, Takanori Teshima, Takeshi Inukai	2
5	Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system 2022 ·International Journal of Hematology ·Thao Nguyen, Minori Tamai, Daisuke Harama, Keiko Kagami, (unknown), Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Takeshi Inukai	3
6	Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia 2021 ·Genes ·Atsushi Watanabe, Kunio Miyake, Koshi Akahane, Kumiko Goi, Keiko Kagami, Hideo Yagita∥, Takeshi Inukai	6
7	IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform 2021 ·Cell Death Discovery ·Daisuke Harama, Takashi Yahata, Keiko Kagami, Masako Abe, (unknown), (unknown), Minori Tamai, Koshi Akahane, Takeshi Inukai, Nobutaka Kiyokawa, Abd Aziz Ibrahim, Kiyoshi Ando, Kanji Sugita	1
8	Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines 2020 ·Cancer Cell International ·Minori Tamai, Meixian Huang, Keiko Kagami, Masako Abe, (unknown), (unknown), Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kanji Sugita, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Takeshi Inukai	5
9	T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system 2018 ·Scientific Reports ·Minori Tamai, Takeshi Inukai, Satoru Kojika, Masako Abe, Keiko Kagami, Daisuke Harama, (unknown), Atsushi Watanabe, (unknown), Koshi Akahane, Kumiko Goi, Eiji Sugihara, Shinichiro Nakada, Kanji Sugita	22
10	Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements 2018 ·Leukemia Research ·(unknown), (unknown), (unknown), Minori Tamai, Daisuke Harama, Keiko Kagami, Masako Abe, Kumiko Goi, Takeshi Inukai, Kanji Sugita	5
11	Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression 2017 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Keiko Kagami, Masako Abe, Takaya Nakane, Kumiko Goi, Takeshi Inukai, Sei Saitoh, Shinichi Ohno, Shogo Okazaki, Osamu Nagano, Hideyuki Saya, Kanji Sugita	8
12	Lack of association between deletion polymorphism of BIM gene and in vitro drug sensitivity in B-cell precursor acute lymphoblastic leukemia 2017 ·Leukemia Research ·Meixian Huang, Kunio Miyake, Keiko Kagami, Masako Abe, (unknown), Atsushi Watanabe, (unknown), (unknown), Kumiko Goi, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Nobutaka Kiyokawa, Kanji Sugita, Takeshi Inukai	5
13	Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia 2015 ·Molecular Cancer Therapeutics ·Atsushi Nemoto, Satoshi Saida, Itaru Kato, Jiro Kikuchi, Yusuke Furukawa, Yasuhiro Maeda, Koshi Akahane, (unknown), Kumiko Goi, Keiko Kagami, Shinya Kimura, Yuko Sato, Seiichi Okabe, Akira Niwa, Kenichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike, Kanji Sugita, Takeshi Inukai	20
14	Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias 2012 ·Leukemia Research ·Atsushi Nemoto, Takeshi Inukai, (unknown), Nobutaka Kiyokawa, Yoshitaka Miyagawa, Kazuya Takahashi, Hiroki Sato, Koshi Akahane, (unknown), (unknown), Kumiko Goi, Keiko Kagami, Shinpei Nakazawa, Junichiro Fujimoto, Toshiya Inaba, Kanji Sugita	1
15	Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor−related apoptosis-inducing ligand-mediated apoptosis 2010 ·Experimental Hematology ·Koshi Akahane, Takeshi Inukai, Xiaochun Zhang, (unknown), (unknown), Kumiko Goi, (unknown), Keiko Kagami, Shinpei Nakazawa, (unknown), Takeo Kubota, Hideo Yagita∥, (unknown), Kanji Sugita	11
16	Fms-like Tyrosine Kinase 3 Ligand Stimulation Induces MLL -Rearranged Leukemia Cells into Quiescence Resistant to Antileukemic Agents 2007 ·Cancer Research ·(unknown), Kumiko Goi, Takeshi Inukai, Hiroki Sato, Atsushi Nemoto, Kazuya Takahashi, Koshi Akahane, (unknown), (unknown), (unknown), Xiaochun Zhang, Keiko Kagami, Yasuhide Hayashi, Kenichi Harigaya, Shinpei Nakazawa, Kanji Sugita	24
17	Induction of Impaired Membrane Phospholipid Asymmetry in Mature Erythrocytes after Chemotherapy 2005 ·International Journal of Hematology ·Xiaochun Zhang, Takeshi Inukai, (unknown), Koshi Akahane, Atsushi Nemoto, Kazuya Takahashi, Hiroki Sato, Keiko Kagami, Kumiko Goi, Kanji Sugita, Shinpei Nakazawa	7
18	Hepatocyte Growth Factor Protects Small Airway Epithelial Cells from Apoptosis Induced by Tumor Necrosis Factor-α or Oxidative Stress 2004 ·Pediatric Research ·Michiyo Okada, Kanji Sugita, Takeshi Inukai, Kumiko Goi, Keiko Kagami, (unknown), Shinpei Nakazawa	53
19	Transient Increase in CD45RO Expression on T Lymphocytes in Infected Newborns 1998 ·Pediatric Research ·(unknown), Kanji Sugita, (unknown), Kumiko Goi, (unknown), Makoto Nakamura, Keiko Kagami, Tetsuo Yokoyama, Shinpei Nakazawa	9
20	Expression of granulocyte colony‐stimulating factor receptor on CD10‐positive human B‐cell precursors 1995 ·British Journal of Haematology ·Takeshi Inukai, Kanji Sugita, (unknown), (unknown), Kumiko Goi, Satoru Kojika, Kyoko Shiraishi, Keiko Kagami, Shinpei Nakazawa	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact